129 related articles for article (PubMed ID: 27053566)
1. Vaxar: A Web-Based Database of Laboratory Animal Responses to Vaccinations and Its Application in the Meta-Analysis of Different Animal Responses to Tuberculosis Vaccinations.
Todd T; Dunn N; Xiang Z; He Y
Comp Med; 2016 Apr; 66(2):119-28. PubMed ID: 27053566
[TBL] [Abstract][Full Text] [Related]
2. Vaxvec: The first web-based recombinant vaccine vector database and its data analysis.
Deng S; Martin C; Patil R; Zhu F; Zhao B; Xiang Z; He Y
Vaccine; 2015 Nov; 33(48):6938-46. PubMed ID: 26403370
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms.
Berke K; Sun P; Ong E; Sanati N; Huffman A; Brunson T; Loney F; Ostrow J; Racz R; Zhao B; Xiang Z; Masci AM; Zheng J; Wu G; He Y
Front Immunol; 2021; 12():639491. PubMed ID: 33777032
[TBL] [Abstract][Full Text] [Related]
5. VIOLIN: vaccine investigation and online information network.
Xiang Z; Todd T; Ku KP; Kovacic BL; Larson CB; Chen F; Hodges AP; Tian Y; Olenzek EA; Zhao B; Colby LA; Rush HG; Gilsdorf JR; Jourdian GW; He Y
Nucleic Acids Res; 2008 Jan; 36(Database issue):D923-8. PubMed ID: 18025042
[TBL] [Abstract][Full Text] [Related]
6. Vaxjo: a web-based vaccine adjuvant database and its application for analysis of vaccine adjuvants and their uses in vaccine development.
Sayers S; Ulysse G; Xiang Z; He Y
J Biomed Biotechnol; 2012; 2012():831486. PubMed ID: 22505817
[TBL] [Abstract][Full Text] [Related]
7. Vaccination markers: designing unique antigens to be added to vaccines to differentiate between natural infection and vaccination.
Root-Bernstein RS
Vaccine; 2005 Mar; 23(17-18):2057-9. PubMed ID: 15755570
[TBL] [Abstract][Full Text] [Related]
8. A rational vaccine pipeline for tuberculosis.
Brennan MJ; Stone MR; Evans T
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
[TBL] [Abstract][Full Text] [Related]
9. Antituberculous vaccine development: a perspective for the endemic world.
Verma I; Grover A
Expert Rev Vaccines; 2009 Nov; 8(11):1547-53. PubMed ID: 19863247
[TBL] [Abstract][Full Text] [Related]
10. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
[TBL] [Abstract][Full Text] [Related]
11. Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG.
Villarreal DO; Walters J; Laddy DJ; Yan J; Weiner DB
Hum Vaccin Immunother; 2014; 10(8):2188-98. PubMed ID: 25424922
[TBL] [Abstract][Full Text] [Related]
12. Databases and in silico tools for vaccine design.
He Y; Xiang Z
Methods Mol Biol; 2013; 993():115-27. PubMed ID: 23568467
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis vaccine development: Shifting focus amid increasing development challenges.
Graves AJ; Hokey DA
Hum Vaccin Immunother; 2015; 11(8):1910-6. PubMed ID: 26125249
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis vaccine research: the impact of immunology.
Barker LF; Brennan MJ; Rosenstein PK; Sadoff JC
Curr Opin Immunol; 2009 Jun; 21(3):331-8. PubMed ID: 19505813
[TBL] [Abstract][Full Text] [Related]
15. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects.
Radosević K; Rodriguez A; Lemckert A; Goudsmit J
Expert Rev Vaccines; 2009 May; 8(5):577-92. PubMed ID: 19397415
[TBL] [Abstract][Full Text] [Related]
16. Exploring local immune responses to vaccines using efferent lymphatic cannulation.
Mahakapuge TA; Every AL; Scheerlinck JP
Expert Rev Vaccines; 2015 Apr; 14(4):579-88. PubMed ID: 25591728
[TBL] [Abstract][Full Text] [Related]
17. The Web-Based DNA Vaccine Database DNAVaxDB and Its Usage for Rational DNA Vaccine Design.
Racz R; He Y
Methods Mol Biol; 2016; 1404():741-752. PubMed ID: 27076334
[TBL] [Abstract][Full Text] [Related]
18. Updates on the web-based VIOLIN vaccine database and analysis system.
He Y; Racz R; Sayers S; Lin Y; Todd T; Hur J; Li X; Patel M; Zhao B; Chung M; Ostrow J; Sylora A; Dungarani P; Ulysse G; Kochhar K; Vidri B; Strait K; Jourdian GW; Xiang Z
Nucleic Acids Res; 2014 Jan; 42(Database issue):D1124-32. PubMed ID: 24259431
[TBL] [Abstract][Full Text] [Related]
19. Extraordinarily few organisms of a live recombinant BCG vaccine against tuberculosis induce maximal cell-mediated and protective immunity.
Horwitz MA; Harth G; Dillon BJ; Maslesa-Galić S
Vaccine; 2006 Jan; 24(4):443-51. PubMed ID: 16125825
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis vaccines: the past, present and future.
Wang J; Xing Z
Expert Rev Vaccines; 2002 Oct; 1(3):341-54. PubMed ID: 12901573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
